NeOnc Technologies (NTHI) Stock: Buy, Sell, or Hold?
NTHI - NeOnc Technologies Holdings, Inc. Common Stock
$3.38
0.05 (1.50%)
▲
5d:
+2.11%
30d:
-27.7%
90d:
-30.74%
HOLD
LOW Confidence
Analysis Updated: Sep 21, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When NTHI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NTHI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NTHI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NTHI is currently trading at $3.38, which is considered oversold relative to its 30-day fair value range of $3.57 to $4.93.
Technical Outlook: Technically, NTHI is in a downtrend. Immediate support is located at $2.96, while resistance sits at $5.02.
Market Sentiment: NTHI scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $16.00 (+380.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NTHI is in a downtrend. Immediate support is located at $2.96, while resistance sits at $5.02.
Market Sentiment: NTHI scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $16.00 (+380.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.57 -
$4.93
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 380.5% below Wall St target ($16.00)
- CAUTION: Bottoming setup, but lagging the sector by 35% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$3.57 -
$4.93
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.96
Resistance Level
$5.02
Current Trend
Downtrend
Technical data as of
Sep 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.31
Wall Street Target
$16.00
(+380.5%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: September 22, 2026 10:49 AM ET
Data refreshes hourly during market hours. Next update: 11:49 AM
Data refreshes hourly during market hours. Next update: 11:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTHI showing a specific setup today?
Insider Activity (6 Months)
8
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yousha Neman-Ebrahim
BUY
500 shares
2026-04-23
Amir F Heshmatpour
BUY
10000 shares
2026-04-23
Amir F Heshmatpour
BUY
10000 shares
2026-04-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 57 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 66 BUY |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$103 | 64 BUY |
|
RLAY
Relay Therapeutics Inc |
STRONG BUY
13 analysts |
$27 | 60 HOLD |